Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation

Antonio Marchetti, Caterina Pellegrini, Fiamma Buttitta, Monica Falleni, Solange Romagnoli, Lara Felicioni, Fabio Barassi, Simona Salvatore, Antonio Chella, Carlo Alberto Angeletti, Massimo Roncalli, Guido Coggi, Silvano Bosari

Research output: Contribution to journalArticle

Abstract

Telomerase activity and telomerase reverse transcriptase (hTERT) expression are elevated in human malignancies. We have investigated telomerase activity measured by the telomeric repeat amplification protocol (TRAP) assay and-hTERT levels by real-time RT-PCR in stage I non-small-cell lung carcinomas. The purposes of our study included the comparison of these two techniques in the assessment of telomerase function and the evaluation of their prognostic significance. Telomerase activity and hTERT levels were determined in 90 stage I non-small-cell lung carcinoma patients, using TRAP assay and real-time RT-PCR, respectively. Variables were analyzed by the X2 and Fisher exact tests. Survival was analyzed by the Kaplan-Meier method. Multivariate analysis was performed with the Cox's proportional hazards model. Telomerase activity was elevated in 60 (67%) carcinomas, hTERT was elevated in 43 (48%) carcinomas. Only 21 (23%) tumors had low telomerase function by both TRAP and hTERT expression levels. Telomerase activity and hTERT were significantly correlated (p = 0.017), although 35 cases displayed discordant results. Both telomerase activity and hTERT levels were significantly associated with poor patient overall and disease-free survival (p = 0.019 and p = 0.018 for TRAP, and p = 0.011 and p = 0.012 for hTERT, respectively). Among the 21 patients with tumors displaying low telomerase function, defined by both TRAP and hTERT expression levels, only one succumbed to the disease (p = 0.0053). Our results suggest that the two techniques used in this study evaluate separate aspects of telomerase function and their combination provides powerful prognostic information in lung cancer patients.

Original languageEnglish
Pages (from-to)729-736
Number of pages8
JournalLaboratory Investigation
Volume82
Issue number6
Publication statusPublished - 2002

Fingerprint

Telomerase
Carcinoma
Lung
Survival
Non-Small Cell Lung Carcinoma
Real-Time Polymerase Chain Reaction
Neoplasms
Proportional Hazards Models
Disease-Free Survival
Lung Neoplasms
Multivariate Analysis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Marchetti, A., Pellegrini, C., Buttitta, F., Falleni, M., Romagnoli, S., Felicioni, L., ... Bosari, S. (2002). Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation. Laboratory Investigation, 82(6), 729-736.

Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation. / Marchetti, Antonio; Pellegrini, Caterina; Buttitta, Fiamma; Falleni, Monica; Romagnoli, Solange; Felicioni, Lara; Barassi, Fabio; Salvatore, Simona; Chella, Antonio; Angeletti, Carlo Alberto; Roncalli, Massimo; Coggi, Guido; Bosari, Silvano.

In: Laboratory Investigation, Vol. 82, No. 6, 2002, p. 729-736.

Research output: Contribution to journalArticle

Marchetti, A, Pellegrini, C, Buttitta, F, Falleni, M, Romagnoli, S, Felicioni, L, Barassi, F, Salvatore, S, Chella, A, Angeletti, CA, Roncalli, M, Coggi, G & Bosari, S 2002, 'Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation', Laboratory Investigation, vol. 82, no. 6, pp. 729-736.
Marchetti A, Pellegrini C, Buttitta F, Falleni M, Romagnoli S, Felicioni L et al. Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation. Laboratory Investigation. 2002;82(6):729-736.
Marchetti, Antonio ; Pellegrini, Caterina ; Buttitta, Fiamma ; Falleni, Monica ; Romagnoli, Solange ; Felicioni, Lara ; Barassi, Fabio ; Salvatore, Simona ; Chella, Antonio ; Angeletti, Carlo Alberto ; Roncalli, Massimo ; Coggi, Guido ; Bosari, Silvano. / Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation. In: Laboratory Investigation. 2002 ; Vol. 82, No. 6. pp. 729-736.
@article{edf49101debf4f50990114e85c255067,
title = "Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation",
abstract = "Telomerase activity and telomerase reverse transcriptase (hTERT) expression are elevated in human malignancies. We have investigated telomerase activity measured by the telomeric repeat amplification protocol (TRAP) assay and-hTERT levels by real-time RT-PCR in stage I non-small-cell lung carcinomas. The purposes of our study included the comparison of these two techniques in the assessment of telomerase function and the evaluation of their prognostic significance. Telomerase activity and hTERT levels were determined in 90 stage I non-small-cell lung carcinoma patients, using TRAP assay and real-time RT-PCR, respectively. Variables were analyzed by the X2 and Fisher exact tests. Survival was analyzed by the Kaplan-Meier method. Multivariate analysis was performed with the Cox's proportional hazards model. Telomerase activity was elevated in 60 (67{\%}) carcinomas, hTERT was elevated in 43 (48{\%}) carcinomas. Only 21 (23{\%}) tumors had low telomerase function by both TRAP and hTERT expression levels. Telomerase activity and hTERT were significantly correlated (p = 0.017), although 35 cases displayed discordant results. Both telomerase activity and hTERT levels were significantly associated with poor patient overall and disease-free survival (p = 0.019 and p = 0.018 for TRAP, and p = 0.011 and p = 0.012 for hTERT, respectively). Among the 21 patients with tumors displaying low telomerase function, defined by both TRAP and hTERT expression levels, only one succumbed to the disease (p = 0.0053). Our results suggest that the two techniques used in this study evaluate separate aspects of telomerase function and their combination provides powerful prognostic information in lung cancer patients.",
author = "Antonio Marchetti and Caterina Pellegrini and Fiamma Buttitta and Monica Falleni and Solange Romagnoli and Lara Felicioni and Fabio Barassi and Simona Salvatore and Antonio Chella and Angeletti, {Carlo Alberto} and Massimo Roncalli and Guido Coggi and Silvano Bosari",
year = "2002",
language = "English",
volume = "82",
pages = "729--736",
journal = "Laboratory Investigation",
issn = "0023-6837",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation

AU - Marchetti, Antonio

AU - Pellegrini, Caterina

AU - Buttitta, Fiamma

AU - Falleni, Monica

AU - Romagnoli, Solange

AU - Felicioni, Lara

AU - Barassi, Fabio

AU - Salvatore, Simona

AU - Chella, Antonio

AU - Angeletti, Carlo Alberto

AU - Roncalli, Massimo

AU - Coggi, Guido

AU - Bosari, Silvano

PY - 2002

Y1 - 2002

N2 - Telomerase activity and telomerase reverse transcriptase (hTERT) expression are elevated in human malignancies. We have investigated telomerase activity measured by the telomeric repeat amplification protocol (TRAP) assay and-hTERT levels by real-time RT-PCR in stage I non-small-cell lung carcinomas. The purposes of our study included the comparison of these two techniques in the assessment of telomerase function and the evaluation of their prognostic significance. Telomerase activity and hTERT levels were determined in 90 stage I non-small-cell lung carcinoma patients, using TRAP assay and real-time RT-PCR, respectively. Variables were analyzed by the X2 and Fisher exact tests. Survival was analyzed by the Kaplan-Meier method. Multivariate analysis was performed with the Cox's proportional hazards model. Telomerase activity was elevated in 60 (67%) carcinomas, hTERT was elevated in 43 (48%) carcinomas. Only 21 (23%) tumors had low telomerase function by both TRAP and hTERT expression levels. Telomerase activity and hTERT were significantly correlated (p = 0.017), although 35 cases displayed discordant results. Both telomerase activity and hTERT levels were significantly associated with poor patient overall and disease-free survival (p = 0.019 and p = 0.018 for TRAP, and p = 0.011 and p = 0.012 for hTERT, respectively). Among the 21 patients with tumors displaying low telomerase function, defined by both TRAP and hTERT expression levels, only one succumbed to the disease (p = 0.0053). Our results suggest that the two techniques used in this study evaluate separate aspects of telomerase function and their combination provides powerful prognostic information in lung cancer patients.

AB - Telomerase activity and telomerase reverse transcriptase (hTERT) expression are elevated in human malignancies. We have investigated telomerase activity measured by the telomeric repeat amplification protocol (TRAP) assay and-hTERT levels by real-time RT-PCR in stage I non-small-cell lung carcinomas. The purposes of our study included the comparison of these two techniques in the assessment of telomerase function and the evaluation of their prognostic significance. Telomerase activity and hTERT levels were determined in 90 stage I non-small-cell lung carcinoma patients, using TRAP assay and real-time RT-PCR, respectively. Variables were analyzed by the X2 and Fisher exact tests. Survival was analyzed by the Kaplan-Meier method. Multivariate analysis was performed with the Cox's proportional hazards model. Telomerase activity was elevated in 60 (67%) carcinomas, hTERT was elevated in 43 (48%) carcinomas. Only 21 (23%) tumors had low telomerase function by both TRAP and hTERT expression levels. Telomerase activity and hTERT were significantly correlated (p = 0.017), although 35 cases displayed discordant results. Both telomerase activity and hTERT levels were significantly associated with poor patient overall and disease-free survival (p = 0.019 and p = 0.018 for TRAP, and p = 0.011 and p = 0.012 for hTERT, respectively). Among the 21 patients with tumors displaying low telomerase function, defined by both TRAP and hTERT expression levels, only one succumbed to the disease (p = 0.0053). Our results suggest that the two techniques used in this study evaluate separate aspects of telomerase function and their combination provides powerful prognostic information in lung cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=0036284709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036284709&partnerID=8YFLogxK

M3 - Article

C2 - 12065683

AN - SCOPUS:0036284709

VL - 82

SP - 729

EP - 736

JO - Laboratory Investigation

JF - Laboratory Investigation

SN - 0023-6837

IS - 6

ER -